IGF2BP2 and nonpapillary renal cell carcinoma: To further elucidate the potential anti‐oncogenic role of IGF2BP2 in ccRCC, we transfected ccRCC cell lines with siRNA or overexpression plasmids of IGF2BP2 (Figure S8A,B).